capivasertib 160 MG Oral Tablet [Truqap]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

capivasertib 160 MG Oral Tablet [Truqap]

160 MG · Oral Tablet · oral

A form of capivasertib →

capivasertib 160 MG Oral Tablet [Truqap] — Other protein kinase inhibitors. Strength, form, class, interactions & more.

capivasertib 160 MG Oral Tablet [Truqap]

Active ingredient

capivasertib →

Classification

Other protein kinase inhibitors

Drug interactions

Capivasertib has several drug interactions primarily involving CYP3A inhibitors and inducers.

  • majorstrong CYP3A inhibitors — increased risk of TRUQAP adverse reactions
  • moderatemoderate CYP3A inhibitors — increased risk of TRUQAP adverse reactions
  • majorstrong CYP3A inducers — reduced effectiveness of TRUQAP
  • majormoderate CYP3A inducers — reduced effectiveness of TRUQAP

Real-world adverse events (FAERS)

Diarrhoea382Death357Rash343Hyperglycaemia248Nausea136Malignant Neoplasm Progression109Vomiting108Fatigue107

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.

Get started freeSee how Eleplan works →